TGF-β neutralization enhances angii-induced aortic rupture and aneurysm in both thoracic and abdominal regions

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Chen, Xiaofeng ^a,b   Rateri, Debra L ^b   Howatt, Deborah A ^b   Balakrishnan, Anju ^b   Moorleghen, Jessica J ^b   Cassis, Lisa A ^b   Daugherty, Alan ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; RENIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL AORTA RUPTURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; AORTA RUPTURE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; THORACIC AORTA ANEURYSM; THORACIC AORTA RUPTURE; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; C57BL MOUSE; CHEMICALLY INDUCED;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; AORTIC RUPTURE; MALE; MICE; MICE, INBRED C57BL; TRANSFORMING GROWTH FACTOR BETA;

EID: 84977656346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153811     Document Type: Article

References (34)

1. Davis FM, Rateri DL, Daugherty A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart. 2014; 100: 1498-1505. doi: 10.1136/heartjnl-2014-305648 PMID: 25060754
2. Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A. Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. Clin Sci. 2012; 123: 531-543. doi: 10.1042/CS20120097 PMID: 22788237
3. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000; 105: 1605-1612. PMID: 10841519
4. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003; 23: 1621-1626. PMID: 12855482
5. Liu J, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Sorci-Thomas M, et al. Associations of apoAI and apoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol. 2015; 35: 1826-1834. doi: 10.1161/ATVBAHA.115.305482 PMID: 26044581
6. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, Ju X, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 2009; 119: 3637-3651. doi: 10.1172/JCI38308 PMID: 19920349
7. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, Cassis LA. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond). 2010; 118: 681-689.
8. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA, Subramanian V, et al. Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ Res. 2011; 108: 574-581. doi: 10.1161/CIRCRESAHA.110.222844 PMID: 21252156
9. Rateri DL, Davis F, Balakrishnan A, Howatt DA, Moorleghen JJ, O'Connor W, et al. Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms. Am J Pathol. 2014; 184: 2586-2595. doi: 10.1016/j.ajpath.2014.05.014 PMID: 25038458
10. Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007; 27: 380-386. PMID: 17158350
11. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006; 312: 117-121. PMID: 16601194
12. Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, et al. Dimorphic Effects of Transforming Growth Factor-β Signaling During Aortic Aneurysm Progression in Mice Suggest a Combinatorial Therapy for Marfan Syndrome. Arterioscler Thromb Vasc Biol. 2015; 35: 911-917. doi: 10.1161/ ATVBAHA.114.305150 PMID: 25614286
13. Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature. 2011; 473: 308-316. doi: 10.1038/nature10145 PMID: 21593863
14. Chen X, Lu H, Rateri DL, Cassis LA, Daugherty A. Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms. Curr Opin Pharmacol. 2013; 13: 180-185. doi: 10.1016/j.coph.2013.01.002 PMID: 23395156
15. Pereira L, Andrikopoulos K, Tian J, Lee SY, Keene DR, Ono R, et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet. 1997; 17: 218-222. PMID: 9326947
16. Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA. 1999; 96: 3819-3823. PMID: 10097121
17. Gallo EM, Loch DC, Habashi J.P., Calderon JF, Chen Y, Bedja D, et al. Angiotensin II-dependent TGFβ signaling contributes to Loeys-Dietz Syndrome vascular pathogenesis. J Clin Invest. 2014; 124: 448-460. doi: 10.1172/JCI69666 PMID: 24355923
18. Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest. 2014; 124: 755-767. doi: 10.1172/JCI69942 PMID: 24401272
19. Hu JH, Wei H, Jaffe M, Airhart N, Du L, Angelov SN, et al. Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice. Arterioscler Thromb Vasc Biol. 2015; 35: 2647-2656. doi: 10.1161/ATVBAHA.115.306573 PMID: 26494233
20. King VL, Lin AY, Kristo F, Anderson TJ, Ahluwalia N, Hardy GJ, et al. Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation. 2009; 119: 426-435. doi: 10.1161/CIRCULATIONAHA.108.785949 PMID: 19139386
21. Spin JM, Hsu M, Azuma J, Tedesco MM, Dyer JS, Maegdefessel L, et al. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol Genomics. 2011; 43: 993-1003. doi: 10.1152/physiolgenomics.00044.2011 PMID: 21712436
22. Dai J, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P, et al. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005; 112: 1008-1015.
23. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest. 2010; 120: 422-432. doi: 10.1172/JCI38136 PMID: 20101093
24. Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Rateri DL, Cassis LA, et al. Subcutaneous angiotensin II infusion using osmotic pumps induces aortic aneurysms in mice. JoVE 2015; 103: e53191.
25. Wang YX, Cassis LA, Daugherty A. Angiotensin II-induced abdominal aortic aneurysms. A Handbook of Mouse Models for Cardiovascular Disease Ed. Xu Q., John Wiley & Sons. 2006; 125-136.
26. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A. Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol. 2011; 179: 1542-1548. doi: 10.1016/j.ajpath.2011.05.049 PMID: 21763672
27. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the chick embryo. Dev Biol 1996; 178: 430-445.
28. Zhou Y, Dirksen WP, Babu GJ, Periasamy M. Differential vasoconstrictions induced by angiotensin II: the role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels. Am J Physiol Heart Circ Physiol. 2003; 285: H2797-2803. PMID: 12907424
29. Owens AP 3rd, Subramanian V, Moorleghen JJ, Guo Z, McNamara CA, Cassis LA, et al. Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ Res. 2010; 106: 611-619. doi: 10.1161/CIRCRESAHA.109.212837 PMID: 20019328
30. Poduri A, Rateri DL, Howatt DA, Balakrishnan A, Moorleghen JJ, Cassis LA, et al. Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II-Induced Medial Hyperplasia in the Ascending Aorta. Arterioscler Thromb Vasc Biol. 2015; 35: 1995-2002. doi: 10.1161/ATVBAHA.115.305995 PMID: 26160957
31. Bush E, Maeda N, Kuziel WA, Dawson TC, Wilcox JN, DeLeon H, et al. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension. 2000; 36: 360-363. PMID: 10988265
32. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992; 90: 456-461. PMID: 1644917
33. Subramanian V, Golledge J, Heywood EB, Bruemmer D, Daugherty A Regulation of peroxisome proliferator-activated receptor-gamma by angiotensin II via transforming growth factor-beta1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2012; 32: 397-405. doi: 10.1161/ATVBAHA.111.239897 PMID: 22095985
34. Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol. 1997; 29: 1947-1958. PMID: 9236148